Pulmonary Hypertensive Vasculopathy Following Tandem Autologous Transplantation in Pediatric Patients with Central Nervous System Tumors

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 235-239

  Schechter, Tal ^a   Leucht, Stephan ^a   Bouffet, Eric ^a   Cutz, Ernest ^a   Gassas, Adam ^a   Huang, Annie ^a   Bartels, Ute ^a   Humpl, Tilman ^a   Doyle, John ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Children; Pulmonary hypertension; Stem Cell Transplantation

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; THIOTEPA; VINCRISTINE;

ARTICLE; ATYPICAL TERATOID RHABDOID TUMOR; AUTOLOGOUS STEM CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM SARCOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CHOROID PLEXUS CARCINOMA; CHOROID PLEXUS SARCOMA; CLINICAL ARTICLE; DRUG FATALITY; DRUG MEGADOSE; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG VASCULAR RESISTANCE; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; PRIMITIVE NEUROECTODERMAL TUMOR; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VASCULAR DISEASES;

EID: 84872604582     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.09.011     Document Type: Article

References (36)

1. Pizzo P.A., Poplack D.G. Principles and Practice of Pediatric Oncology 2006, Lippincott Williams & Wilkins, Philadelphia. Fifth ed.
2. Packer R.J., Gajjar A., Vezina G., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006, 25:4202-4208.
3. Packer R.J., Biegel J.A., Blaney S., et al. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 2002, 24:337-342.
4. Bouffet E., Tabori U., Huang A., et al. Possibilities of new therapeutic strategies in brain tumors. Cancer Treat Rev 2010, 36:335-341.
5. Radcliffe J., Bunin G.R., Sutton L.N., et al. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation. Int J Dev Neurosci 1994, 12:327-334.
6. Costine L.S., Woolf P.D., Cann D., et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. New Engl J Med 1993, 328:87-94.
7. Zeltzer P.M., Boyett J.M., Finlay J.L., et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 Randomized Phase III study. J Clin Oncol 1999, 17:832-839.
8. Dhall G., Grodman H., Ji L., et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer 2008, 50:1169-1175.
9. Gardner S.L., Asgharzadeh S., Green A., et al. Intensive induction chemotherapy followed by high-dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 2008, 51:235-240.
10. Geyer J.R., Sposto R., Jennings M., et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005, 23:7621-7631.
11. Grill J., Dufour C., Kalifa C. High-dose chemotherapy in children with newly diagnosed medulloblastoma. Lancet Oncol 2006, 7:787-789.
12. Gilman A.L., Jacobsen C., Bunin N., et al. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and Marrow Transplant Consortium study. Pediatr Blood Cancer 2011, 57:506-513.
13. Foreman K., Schissel D., Le T., et al. A study of sequential high-dose cyclophosphamide and high-dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors. J Neurooncol 2005, 71:181-187.
14. Badesch D.B., Champion H.C., Sanchez M.A., et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54(Suppl 1):S55-S66.
15. Ozkaynak M.F., Sandoval C., Levendoglu-Tugal O., et al. A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central nervous system tumors. Pediatr Hematol Oncol 2004, 21:635-645.
16. Finkelstein-Shechter T., Gassas A., Mabbott D., et al. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 2010, 32:e182-e186.
17. Sung K.W., Yoo K.H., Cho E.J., et al. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Pediatr Blood Cancer 2007, 48:408-415.
18. Galie N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009, 34:1219-1263.
19. Langston C., Patterson K., Dishop M.K., et al. A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the Child Pathology Cooperative Group. Pediatr Dev Pathol 2006, 9:173-180.
20. Bentur L., Cullinane C., Wilson P., et al. Fatal pulmonary arterial occlusive vascular disease following chemotherapy in a 9-month-old infant. Hum Pathol 1991, 22:1295-1298.
21. Vaksmann G., Nelken B., Deshildre A., et al. Pulmonary arterial occlusive disease following chemotherapy and bone marrow transplantation for leukaemia. Eur J Pediatr 2002, 161:247-249.
22. Steward C.G., Pellier I., Mahajan A., et al. Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br J Haematol 2004, 124:63-71.
23. Zacharoulis S., Levy A., Chi S.N., et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer 2007, 49:34-40.
24. Fangusaro J., Massimino M., Rutkowski S., et al. Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state-of-the-art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents. Pediatr Blood Cancer 2010, 54:638-640.
25. Gilheeney S.W., Khakoo Y., Souweidane M., et al. Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system. Pediatr Blood Cancer 2010, 54:591-595.
26. Chi S.N., Zimmerman M.A., Yao X., et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009, 27:385-389.
27. Mason W.P., Gravas A., Halpern S., et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 1998, 16:210-221.
28. Finlay J.L., Dhall G., Boyett J.M., et al. Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy. A report from the Children's Oncology Group. Pediatr Blood Cancer 2008, 51:806-811.
29. Seguchi M., Hirabayashi N., Fujii Y., et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000, 69:177-179.
30. Hackman R.C., Madtes D.K., Petersen F.B., et al. Pulmonary veno-occlusive disease following bone marrow transplantation. Transplantation 1989, 47:989-992.
31. Grigg A., Buchanan M., Whitford M. Late-onset pulmonary arterial hypertension in association with graft-versus-host disease after allogeneic stem-cell transplantation. Am J Hematol 2005, 80:38-42.
32. Malhotra P., Varma S., Varma N., et al. Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation. Am J Hematol 2005, 80:164-165.
33. Trobaugh-Lotrario A.D., Greffe B., Deterding R., et al. Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. J Ped Hematol Oncol 2003, 25:405-409.
34. Holocomb B.W., Loyd J.E., Ely E.W., et al. Pulmonary veno-occlusive disease: a case series and new observations. Chest 2000, 118:1671-1679.
35. Stenmark K.R., Meyrick B., Galie N., et al. Animal models of pulmonary arterial hypertension: hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009, 297:L1013-L1032.
36. Ferreira A.J., Shenoy V., Yamazato Y., et al. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med 2009, 179:1048-1054.